Bausch Health Expands Aesthetics Footprint with Clear + Brilliant Touch Laser Launch in Canada
Event summary
- Bausch Health's Solta Medical launched the Clear + Brilliant® Touch laser in Canada on February 23, 2026, following Health Canada approval on May 20, 2025.
- The dual-wavelength laser system is designed for non-invasive skin rejuvenation, targeting wrinkles, pigmentation, and skin texture.
- The device builds on Solta Medical's existing U.S. launch in 2021 and is supported by over 15 clinical studies.
- Bausch Health positions the launch as part of its global expansion strategy in the aesthetics market.
The big picture
Bausch Health's launch of the Clear + Brilliant® Touch laser in Canada aligns with the growing demand for non-invasive aesthetic treatments. The move underscores Solta Medical's strategy to expand its global footprint, leveraging its established portfolio in a market with strong interest in skin health solutions. The approval by Health Canada further validates the device's safety and efficacy, positioning it as a key player in the Canadian aesthetics landscape.
What we're watching
- Market Penetration
- How quickly the Clear + Brilliant® Touch laser gains adoption among Canadian physicians and patients.
- Revenue Growth
- Whether the Canadian launch can drive meaningful revenue contributions to Bausch Health's aesthetics segment.
- Competitive Dynamics
- The pace at which competitors respond with similar non-invasive skin rejuvenation technologies in Canada.
Related topics